Investing Profile

Jonathan Root

VCInvestor
General Partner at U.S. Venture Partners
usvp.com/team/jon-root/Menlo Park, California
Photo of Jonathan Root, General Partner at U.S. Venture Partners (USVP)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
U.S. Venture Partners Network
16 CONNECTIONS
cb
$2.0M - $10.0M
$6.0M
29
$400M
CompanyStageDateRound SizeTotal Raised
Route 92 Medical
Private EquityApr 2026$50M
Series FSep 2024$50M
$190M
Co-investors: Casper de Clercq (Norwest Venture Partners)
Okami Medical
Series FNov 2025$45M
Series UnknownOct 2024$33M
Series DJun 2020$7M
$85M
Sparrow Pharmaceuticals
Series BSep 2025$95M
$160M
Co-investors: Klaus Veitinger (OrbiMed), Nanna Luneborg (Forbion), Zach Scheiner (RA Capital Management)
Nervonik
Series AMar 2025$13M
$13M
Carlsmed
Series CMar 2024$64M
Series ADec 2020$10M
$100M
Co-investors: Robert Mittendorff (B Capital Group), Widya Mulyasasmita (BEVC)
Aimbient (formerly SST)
Series AMay 2023$15M
$15M
Co-investors: Dafina Toncheva (U.S. Venture Partners (USVP)), Dennis Mcwilliams (Santé Ventures)
HealthJoy
Series DOct 2022$60M
$130M
Co-investors: Aneesha Mehta (Bain Capital Ventures), Stuart Larkins (Chicago Ventures), Saurabh Bhansali (Health Velocity Capital), Martin Alexander Gershon (Endeavor Venture Funds), Daniel van den Bergh (Kaiser Permanente Ventures), Jack Boren
Effector Therapeutics
Post Ipo EquityAug 2021$60M
$200M
Co-investors: Maha Katabi (Sofinnova Investments), Bill Harrington (Osage University Partners (OUP))
General Partner U.S. Venture PartnersPresent
Sign in with Google →
Sign in with Google →